Detalhe da pesquisa
1.
Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.
Eur Heart J
; 44(39): 4157-4173, 2023 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37611089
2.
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.
Eur Heart J
; 44(25): 2277-2291, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37130090
3.
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.
Eur Heart J
; 43(39): 3925-3946, 2022 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-36036785
4.
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.
Eur Heart J
; 42(47): 4791-4806, 2021 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34472586
5.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Cardiovasc Diabetol
; 18(1): 71, 2019 06 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31164165
6.
Combination lipid-lowering therapy as first-line strategy in very high-risk patients.
Eur Heart J
; 43(8): 830-833, 2022 02 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34636884
7.
A Woman's Heart: Improving Uptake and Awareness of Cardiovascular Screening for Middle-Aged Populations.
Int J Womens Health
; 15: 1171-1183, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37520181
8.
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.
Atherosclerosis
; 374: 107-120, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37188555
9.
Pulmonary arterial hypertension associated with congenital heart disease: lessons learnt from the large Turkish Nationwide Registry (THALES).
Pulm Circ
; 11(3): 20458940211024206, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34211699
10.
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.
Atherosclerosis
; 325: 99-109, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33892925